AstraZeneca signs $443M deal to buy Princeton drug maker

Home › AstraZeneca signs $443M deal to buy Princeton drug maker

AstraZeneca entered into a definitive agreement Tuesday to acquire Omthera Pharmaceuticals in a deal valued at up to $443 million.

07.10	Mark Andy appoints Antony Cotton European sales manager
07.10	Hurricane Milton Potential Storm Surge Flooding Map
07.10	Evonik, BASF Agree on First Delivery of Biomass-Balanced Ammonia
07.10	Hurricane Milton Update Statement
07.10	Summary for Hurricane Milton (AT4/AL142024)
07.10	Hurricane Milton Probabilistic Storm Surge Graphics
07.10	MCC acquires smart label solutions provider Starport Technologies
07.10	UPM Raflatac announces Packaging Recyclability Guide
More »

je.st